Abstract:Abstract Multiple myeloma (MM) is a disease characterized by the uncontrolled proliferation and accumulation of malignant plasma cells in the bone marrow. Cancer cells are characterized by a profound genetic instability resulting in a complex set of numerical and structural chromosomal abnormalities. We previously cloned a tumor-associated gene C1orf35 from MM cell line ARH-77, which located the chromosome 1q42.13. The results showed that C1orf35 could promote the transformation, cell growth and proliferation of NIH3T3 cells, as well as cell transition from phase G1 to S. C1orf35 also possessed the potentials of promoting tumor formation in animal experiments. Based on this finding, we further explored the molecular mechanism of C1orf35 gene up-regulation and its effects on pathogenesis of human MM. The expression level of C1orf35 gene in MM patients was detected by RT-PCR. The gene expression of C1orf35 in mononuclear cells of MM patients was up-regulated (68.9%), and was not detectable in normal controls. The lentivirus vector GV248/C1orf35-RNAi for interference experiments was constructed and the NIH3T3/C1orf35-RNAi cell line which stable expressed C1orf35-RNAi was set up. The expression level of C1orf35 in NIH3T3/C1orf35-RNAi cells was detected by real-time PCR and Western blotting. The results showed that the expression levels of both mRNA and protein were down-regulated and the cell proliferation was markedly decreased after interference. By detecting the c-myc expression level of NIH3T3/Clorf35-RNAi cells, we found that expression level of c-myc gene and protein all decreased. These results indicated that down-regulation of C1orf35 was followed by down-regulation of c-myc, which implied C1orf35 might play an important role in c-myc-dependent pathway. To investigate the effects of C1orf35 gene on proliferation of MM cells, we interfered and over-expressed C1orf35 gene. The results showed that the cell proliferation was obviously decreased after interference, and the cell proliferation was significantly accelerated after over-expression of C1orf35 gene. The bioinformatics analysis showed that C1orf35 protein was located in nucleus and might play an important role for transcription regulation, which may participate in the activation of some oncogenes. We detected the binding of C1orf35 protein and promoter region of proto-oncogene c-myc with chromatin immunoprecipitation assay (ChIP) and the results showed that C1orf35 protein binds promoter region of c-myc in -226 to -10 bp. This work may contribute to reveal the role of C1orf35 in MM pathogenesis. Note: This abstract was not presented at the meeting. Citation Format: Wei-Xin Hu, Sai-Qun Luo, Yan Zhong, Xiu-Feng Bu, Yang Zhou. The studies of tumor-associated gene C1orf35 in pathogenesis of human multiple myeloma. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr LB-070. doi:10.1158/1538-7445.AM2015-LB-070

Identification and Characterization of a Novel Gene, C1orf109, Encoding a CK2 Substrate That is Involved in Cancer Cell Proliferation

The Novel MGC13096 Protein is Correlated with Proliferation.

C1orf109L promote R-loop accumulation induced DNA damage to inhibit cell growth

Pan-Cancer Analysis Identified C1ORF112 as a Potential Biomarker for Multiple Tumor Types

C1orf106, an Innate Immunity Activator, is Amplified in Breast Cancer and is Required for Basal-Like/luminal Progenitor Fate Decision

Evolution, structure and emerging roles of C1ORF112 in DNA replication, DNA damage responses, and cancer

The Nucleolar Protein C1orf131 Is a Novel Gene Involved in the Progression of Lung Adenocarcinoma Cells through the AKT Signalling Pathway

C1orf106 (INAVA) Is a SMAD3-Dependent TGF-β Target Gene That Promotes Clonogenicity and Correlates with Poor Prognosis in Breast Cancer

The Role of C2orf68 and PI3K/Akt/mTOR Pathway in Human Colorectal Cancer

Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study

C1orf109L Binding DHX9 Promotes DNA Damage Depended on the R‐loop Accumulation and Enhances Camptothecin Chemosensitivity

Identification and characterization of CAC1 as a novel CDK2-associated cullin.

Sa1693 the Role of C9orf140 in Colorectal Cancer Invasion

Abstract LB-070: the Studies of Tumor-Associated Gene C1orf35 in Pathogenesis of Human Multiple Myeloma

Identification and Expression Analysis of A Novel Cw-Type Zinc Finger Protein Morc2 in Cancer Cells

C20orf27 Promotes Cell Growth and Proliferation of Colorectal Cancer Via the TGFβR-TAK1-NFĸB Pathway

C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis

Identification of Rcop-1, a New Member of the CCN Protein Family, As a Negative Regulator for Cell Transformation

TC1 (C8orf4) is involved in ERK1/2 pathway-regulated G1- to S-phase transition

CIRH1A Augments the Proliferation of RKO Colorectal Cancer Cells.

C10ORF97 is a Novel Tumor-Suppressor Gene of Non-Small-cell Lung Cancer and a Functional Variant of This Gene Increases the Risk of Non-Small-cell Lung Cancer